已发表论文

IL-27 在体外通过 miR-935 抑制非小细胞肺癌细胞转移

 

Authors Wang T, Chen Y, Nie H, Huang Y, Zhao Y, Yang J

Received 5 May 2018

Accepted for publication 24 August 2018

Published 21 February 2019 Volume 2019:12 Pages 1447—1454

DOI https://doi.org/10.2147/OTT.S173207

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Ru Chen

Peer reviewer comments 3

Editor who approved publication: Dr William Cho

Introduction: Non-small-cell lung cancer (NSCLC) accounts for more than half of all lung cancer cases. Cytokines play an important role in NSCLC, including IL-27. IL-27 inhibits NSCLC progression; however, the mechanism is not clear. The purpose of this study is to investigate the effects of IL-27 on NSCLC cell proliferation and metastasis. 
Materials and methods: NSCLC cells were treated with IL-27 or transfected with miR-935, and the cell proliferation was assayed by Cell Counting Kit-8 (CCK-8) and colony formation. Cell metastasis was analyzed by Transwell chamber system and wound healing assay. IL-27 protein in the medium was analyzed by ELISA. IL-27 mRNA expression was measured by quantitative reverse transcriptase-PCR. 
Results: We found that IL-27 played an inhibiting role in NSCLC cell proliferation and metastasis. The molecular mechanism of the suppressing role of IL-27 in NSCLC was regulated by miR-935. IL-27 expression was negatively associated with miR-935 in the clinical NSCLC samples. 
Conclusion: The study revealed that IL-27 decreased lung cancer cell proliferation and metastasis via miR-935.
Keywords: non-small cell lung cancer, IL-27, miR-935




Figure 1 IL-27 expression was lower in clinical NSCLC samples.